The Immunoassay Reagents and Devices Industry will relinquish an approximated estimate at a frequency of 4.70% for the projection space of 2021 to 2028 with factor such as the rising incidence of chronic and infectious diseases and wide application of immunoassay. Increase in the emergence of COVID-19 pandemic have surged the use of immunoassay reagents and devices as a major factor for the growth of the immunoassay reagents and devices market.
Technological upgradation and advancements have propelled the demand of the immunoassay reagents and devices market. However, availability of alternative technology has expected to decrease the demand of the immunoassay reagents and devices market.
Immunoassay Reagents and Devices Market Scenario
According to Data Bridge Market Research, the market for Immunoassay reagents and devices in North America has the highest market share. Market leader is F. Hoffmann-La Roche Ltd which accounts an estimated market share of approximately 35% to 38% North America. The company has gained outstanding sale by new product launch of immunoassay reagents and devices.
- In April 2021, F. Hoffmann-La Roche Ltd launched five new intended uses for two key cardiac biomarkers using the Elecsys technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks (cTnT-hs) and better manage heart failure (NT-proBNP). This will help the company to improve its product portfolio and enhance its market share.
Trends Impacting the Immunoassay Reagents and Devices Market
Now the question is which other regions F. Hoffmann-La Roche Ltd, Abbott and DiaSorin S.p.A are targeting? Data Bridge Market Research has forecasted a large growth in North America immunoassay reagents and devices market and the market leaders targeting the U.S. and Canada to be their next pocket revenue for 2021.
The immunoassay reagents and devices market is becoming more competitive with companies such as F. Hoffmann-La Roche Ltd, Abbott and DiaSorin S.p.A. These are the top dominating companies in immunoassay reagents and devices market and have launched new products in the market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the North America immunoassay reagents and devices market.
For more analysis on the North America immunoassay reagents and devices market, request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=north-america-immunoassay-reagents-and-devices-market
Immunoassay Reagents and Devices Market Development
- In April 2021, F. Hoffmann-La Roche Ltd launched the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. This test is used to aid physicians to diagnose throat cancer, bowel cancer and breast cancer in patients, in conjunction with other diagnostic tests.
Scope of the Immunoassay Reagents and Devices Market
North America immunoassay reagents and devices market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, Italy, France, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, rest of Europe, China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines, rest of North America , Brazil, Argentina, rest of South America, Saudi Arabia, South Africa, Egypt, UAE, Israel and rest of Middle East and Africa.
- All country based analysis of the North America immunoassay reagents and devices market is further analysed based on maximum granularity into further segmentation. On the basis of product, the immunoassay reagents and devices market is segmented into reagents & kits and analyzers. On the basis of platform, the immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassay, radioimmunoassays and others. On the basis of technique, the immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR and other techniques. On the basis of specimen type, the immunoassay reagents and devices market is segmented into saliva, urine, blood and others. On the basis of application, the immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening and other applications. On the basis of end user, the immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research & academic laboratories and others.
To know more about the study https://www.databridgemarketresearch.com/reports/north-america-immunoassay-reagents-and-devices-market
Key Pointers Covered in Immunoassay Reagents and Devices Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market Value and Over View of Immunoassay Reagents and Devices
- Company Profiling of Top Eight Players of Immunoassay Reagents and Devices Market
Key Market Competitors Covered in the Report
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- Abbott
- Randox Laboratories Ltd.
- Agilent Technologies, Inc.
- Luminex Corporation
- BD
- Beckman Coulter, Inc. (a subsidiary of Danaher)
- BioCheck, Inc.
- Bio-Techne
- DiaSorin S.p.A
- Merck KGaA
- MESO SCALE DIAGNOSTICS, LLC
- Ortho Clinical Diagnostics
- PerkinElmer Inc.
- Quidel Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Siemens
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- QIAGEN
Above are the key players covered in the report, to know about more and exhaustive list of immunoassay reagents and devices companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=north-america-immunoassay-reagents-and-devices-market
Research Methodology: North America Immunoassay Reagents and Devices Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturers, Food Industrialists, Scientists and Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.
Related Reports
- North America Radio Immunoassay (RIA) Reagents and Devices Market - Industry Trends and Forecast to 2027
- North America Enzyme Immunoassay (EIA) Reagents and Devices Market - Industry Trends and Forecast to 2028
- North America Immunoassay Reagents and Devices Market - Industry Trends and Forecast to 2027
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
